Comparison of Plasma Neutrophil Gelatinase - Associated Lipocalin (NGAL) Levels

Sponsor
Antalya Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03607279
Collaborator
(none)
66
1
7
9.5

Study Details

Study Description

Brief Summary

The purpose of the study is to compare the effect of two surgical techniques (open vs robotic assisted) on plasma levels of NGAL (neutrophil gelatinase-associated lipocalin) after radical prostatectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: NGAL

Detailed Description

Patients undergoing radical prostatectomy are at increased risk of acute kidney injury (AKI) because of intraoperative bleeding, obstructive uropathy and older age. In particular robot-assisted laparoscopic radical prostatectomy (RALP) which is in increasing demand as an alternative surgical option for retropubic radical prostatectomy (RRP) is associated with postoperative renal dysfunction because pneumoperitoneum during RALP can decrease cardiac output and renal perfusion. NGAL may become important for diagnosis of postoperative AKI after urogenital oncosurgery.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
66 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Comparison of Plasma Neutrophil Gelatinase - Associated Lipocalin (NGAL) Levels After Robot-assisted Laparoscopic Versus Retropubic Radical Prostatectomy
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
NGAL - retropubic radical prostatectomy

Plasma NGAL was determined at baseline, 6 and 12 hrs after induction of anaesthesia

Procedure: NGAL

NGAL - robotic radical prostatectomy

Plasma NGAL was determined at baseline, 6 and 12 hrs after induction of anaesthesia

Procedure: NGAL

Outcome Measures

Primary Outcome Measures

  1. Plasma NGAL [0 hours, 6 hours and 12 hours after surgery]

    Plasma NGAL was determined at baseline, 6 hours and 12 hours after surgery, ng/ml

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients who undergo prostatectomy

  • American Society of Anesthesiology (ASA) I-III

Exclusion Criteria:
  • preexisting renal disease

  • emergency surgery

  • heart failure

  • peripheral vascular disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation Antalya Turkey 07100

Sponsors and Collaborators

  • Antalya Training and Research Hospital

Investigators

  • Principal Investigator: Arzu Karaveli, Netherlands: Ministry of Health, Welfare and Sports

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Arzu Karaveli, Study director, Antalya Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT03607279
Other Study ID Numbers:
  • 2016-118
First Posted:
Jul 31, 2018
Last Update Posted:
Dec 19, 2018
Last Verified:
Dec 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Arzu Karaveli, Study director, Antalya Training and Research Hospital

Study Results

No Results Posted as of Dec 19, 2018